Fibulin 5 anticorps
-
- Antigène Voir toutes Fibulin 5 (FBLN5) Anticorps
- Fibulin 5 (FBLN5)
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Fibulin 5 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Synthetic peptide of human FBLN5
- Isotype
- IgG
- Top Product
- Discover our top product FBLN5 Anticorps primaire
-
-
- Indications d'application
- IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.2 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- Fibulin 5 (FBLN5)
- Autre désignation
- Fibulin 5 (FBLN5 Produits)
- Synonymes
- anticorps zgc:103575, anticorps FBLN5, anticorps MGC108414, anticorps Fibulin-5, anticorps DKFZp469K0327, anticorps ADCL2, anticorps ARCL1A, anticorps ARMD3, anticorps DANCE, anticorps EVEC, anticorps FIBL-5, anticorps UP50, anticorps A55, anticorps fibulin 5, anticorps fbln5, anticorps FBLN5, anticorps Fbln5
- Sujet
- The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3).
- NCBI Accession
- NP_006320
- UniProt
- Q9UBX5
- Pathways
- SARS-CoV-2 Protein Interactome
-